Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Corvus Pharma Com (NQ: CRVS )

0.8640 +0.0235 (+2.80%)
Streaming Delayed Price Updated: 3:57 PM EST, Feb 3, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 47,001
Open 0.8687
Bid (Size) 0.8411 (5)
Ask (Size) 0.8688 (16)
Prev. Close 0.8405
Today's Range 0.8202 - 0.8687
52wk Range 0.6950 - 2.170
Shares Outstanding 46,553,511
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
$1 Million Bet On BioCardia? Check Out These 4 Penny Stocks Insiders Are Buying
The Dow Jones settled higher on Tuesday after recording losses for four straight sessions. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
4 Penny Stocks Insiders Are Buying: Getaround, Corvus Pharmaceuticals And More
The Dow Jones closed lower by over 700 points on Thursday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern... 
Via Benzinga

Performance

YTD
-0.37%
-0.37%
1 Month
-6.32%
-6.32%
3 Month
+3.47%
+3.47%
6 Month
-5.68%
-5.68%
1 Year
-48.57%
-48.57%

More News

Read More
Why OpGen Shares Are Trading Higher By 220%? Here Are 64 Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Earnings Scheduled For March 10, 2022
Via Benzinga
Corvus Pharmaceuticals Presents Updated Data from CPI-818 (ITK Inhibitor) Phase 1/1b Clinical Trial at the 64th American Society of Hematology (ASH) Annual Meeting & Exposition
From Corvus Pharmaceuticals, Inc.
Via Globe NewsWire
Corvus Pharmaceuticals to Host Investor Conference Call and Webcast on December 12, 2022
From Corvus Pharmaceuticals, Inc.
Via Globe NewsWire
James Rosenbaum Presented the Distinguished Service Award by the American College of Rheumatology
From Corvus Pharmaceuticals, Inc.
Via Globe NewsWire
Corvus Pharmaceuticals Provides Business Update and Reports Third Quarter 2022 Financial Results
From Corvus Pharmaceuticals, Inc.
Via Globe NewsWire
Corvus Pharmaceuticals to Present Updated CPI-818 (ITK Inhibitor) Data at the 64th American Society of Hematology (ASH) Annual Meeting & Exposition
From Corvus Pharmaceuticals, Inc.
Via Globe NewsWire
Earnings Preview For Corvus Pharmaceuticals
Via Benzinga
Corvus Pharmaceuticals to Provide Business Update and Report Third Quarter 2022 Financial Results on November 3, 2022
From Corvus Pharmaceuticals, Inc.
Via Globe NewsWire
Corvus Pharmaceuticals Announces Initiation of Phase 1b/2 Clinical Trial of Ciforadenant as Potential First Line Treatment for Patients with Renal Cell Cancer
From Corvus Pharmaceuticals, Inc.
Via Globe NewsWire
Benzinga's Top Ratings Upgrades, Downgrades For October 7, 2022
Via Benzinga
10 Best Stocks to Buy Now According to Jeffrey Diehl’s Adams Street Partners
Via Talk Markets
Corvus Pharma's Partner Secures China Approval For Early-Stage Mupadolimab Trial For Lung, Head & Neck Cancer
Via Benzinga
Corvus Pharmaceuticals: Q2 Earnings Insights
Via Benzinga
Recap: Corvus Pharmaceuticals Q4 Earnings
Via Benzinga
A Preview Of Corvus Pharmaceuticals's Earnings
Via Benzinga
The Daily Biotech Pulse: Bausch Files For Eye Health Unit IPO, LumiraDx Antigen Test Can Detect Omicron, Molecular Partners Discloses Fund Stake
Via Benzinga
This Healthcare Stock Jumps Around 188%, Here's 83 Biggest Movers From Yesterday
Via Benzinga
Carnival Surges Over 12%, Here's 75 Biggest Movers From Friday
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
The Week Ahead In Biotech (March 6-12): Quiet Week On Tap With Earnings Season Reaching It Final Leg
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.